Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

442.33 +5.84 (+1.34%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Here's Why I Still Own Alexandria Real Estate Equities
This office owner is not like the rest, which could be a very good thing. 
Via The Motley Fool
Looking At Eli Lilly's Recent Unusual Options Activity
 
Via Benzinga
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
Analysts are bullish on Biogen's Alzheimer's drug, Leqembi, projecting it may generate over $10 billion in sales at its peak. 
Via The Motley Fool
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth. 
Via MarketBeat
Topics Economy
Exposures Economy
This Is What Whales Are Betting On Eli Lilly
 
Via Benzinga
What 20 Analyst Ratings Have To Say About Eli Lilly
 
Via Benzinga
3 Growth Stocks to Buy and Hold
These three stocks defied the bear market last year. 
Via The Motley Fool
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. 
Via MarketBeat
Exposures Product Safety
Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
Investors are busy looking at tech stocks, but they should be looking for healthcare stocks to buy, as this group powers to new highs. 
Via InvestorPlace
Billionaire Investor Stanley Druckenmiller Warns Of 'Biggest And Probably Broadest Asset Bubble' — Here's How He's Preparing For 'The Grand Finale'
By increasing borrowing costs and reducing liquidity, interest rate hikes have the potential to cool asset bubbles. But despite the Federal Reserve’s aggressive rate hikes, billionaire investor Stanley... 
Via Benzinga
Is Novo Nordisk Stock a Screaming Buy Right Now?
The drugmaker's shares have crushed the broader markets over the past two years. Can it keep up this blistering momentum? 
Via The Motley Fool
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
It's a lot more likely than it might sound at first. 
Via The Motley Fool
Eli Lilly and Company (NYSE: LLY) Climbs to New 52-Week High
Via Investor Brand Network
The Turnaround for Weight Watchers is Taking Shape
Weight management meals and services provider WW International Inc. (NYSE: WW) stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares 
Via MarketBeat
Eli Lilly's Alzheimer's Drug Is Just Version 1.0. But It's Still On Track For Blockbuster Status, Analyst Says.
An analyst says Lilly's donanemab could become a blockbuster in its second year on the market. 
Via Investor's Business Daily
Oral Cancer Treatment Market Projected to Show Strong Growth : Bristol-Myers Squibb, Qilu Pharmaceutical, Novartis
Get Oral Cancer Treatment Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis. 
Via SBWire
These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win
There's no rule that says a market must have only one winner. 
Via The Motley Fool
Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing
CEOs of Eli Lilly And Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and PBM e 
Via Benzinga
AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market
 
Via Benzinga
Here’s What Eli Lilly’s Latest Clinical Win Means For Investors
The biotech's prospects continue to get brighter. 
Via The Motley Fool
Jim Cramer Hates Being 'Downbeat,' But Warns: Default On Debt Would Affect Geopolitical Face Of US
 
Via Benzinga
Worsening Alzheimer’s Epidemic Signals A Need for More Community Memory Screening
Via AB Newswire
Exposures COVID-19
Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal
Eli Lilly stock may look expensive, but there's still plenty of value here for long-term investors. 
Via The Motley Fool
The 3 Best MedTech Stocks to Watch in May 2023
Here's a look at the best MedTech stocks to watch in May, which include Teladoc, Veeva and iRhythms Technology. 
Via InvestorPlace
Obesity Drug Achieves ~15% Weight Loss - Zealand Pharma-Boehringer Ingelheim Partnered Drug May Compete With Novo Nordisk, Eli Lilly
Boehringer Ingelheim and Zealand Pharma A/S (OTC: ZLDPF) announced that patients treated with BI 456906  
Via Benzinga
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street. 
Via Benzinga
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which... 
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023
These best healthcare dividend stocks offer tremendous upside and stability in the current volatile macro environment 
Via InvestorPlace
Eli Lilly and Company (NYSE: LLY) Sets New 52-Week High in Monday Session
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.